G. De Cicco

Maintenance therapy with bortezomib and dexamethasone after autotransplantation for high-risk multiple myeloma

E. Borsi, E. Zamagni, N. Testoni, 2020, Bone Marrow Transplantation.

Saprochaete clavata infections in patients undergoing treatment for haematological malignancies: A report of a monocentric outbreak and review of the literature

Russell E. Lewis, S. Paolini, F. Bonifazi, 2019, Mycoses.

Subcutaneous bortezomib-containing regimens as up-front treatment of newly diagnosed transplant-eligible multiple myeloma patients: a retrospective, non-interventional observational study

E. Zamagni, V. De Stefano, P. Tosi, 2021, Leukemia & lymphoma.

Impact of minimal residual disease standardised assessment by FDG-PET/CT in transplant-eligible patients with newly diagnosed multiple myeloma enrolled in the imaging sub-study of the FORTE trial

M. Boccadoro, C. Nanni, S. Fanti, 2023, EClinicalMedicine.

Role of serum‐free light chain assay for defining response and progression in immunoglobulin secretory multiple myeloma

E. Zamagni, N. Testoni, M. Cavo, 2022, American journal of hematology.